Translate Bio Announces FDA Clinical Hold on Investigational New Drug Application (IND) for MRT5201 for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency
Stock Information for Telesis Bio Inc.
Loading
Please wait while we load your information from QuoteMedia.